加密巨头Tether被曝拟融资200亿美元,试图跻身5000亿估值俱乐部

金十数据2025-09-24 tarihinde yayınlandı2025-09-24 tarihinde güncellendi

全球最大稳定币的发行商Tether Holdings SA正与投资者洽谈,拟融资高达200亿美元,这笔交易可能将这家加密货币公司推向全球最有价值私营公司的最高行列。

据两位知情人士透露,这家总部位于萨尔瓦多的公司正寻求通过私募方式,以约3%的股份换取150亿至200亿美元的资金。

另一位参与该过程的人士告诫说,这是最高的目标,最终的数字可能会低得多。知情人士称,谈判尚处于早期阶段,拟议投资的细节可能会改变。

根据所提供的股份比例,这笔交易对该公司的估值可能在5000亿美元左右,使其与OpenAI和马斯克的SpaceX处于同一梯队。

即便在竞争对手成倍增加、美国利率下降威胁其意外之财的情况下,这对这家监管宽松的加密货币企业来说也是一项非凡的成就,其最直接的竞争对手、公开上市的稳定币发行商Circle Internet Group Inc.截至周二的市值约为300亿美元。

知情人士说,该交易将涉及发行新股,而非现有投资者出售其股份。他们补充说,美国金融服务公司Cantor Fitzgerald担任首席顾问。

前白宫加密货币官员、Tether的数字资产和美国战略战略顾问Bo Hines周二在首尔一个会议的采访中表示,Tether没有融资计划。 Tether的其他代表未提供评论。Cantor Fitzgerald的发言人拒绝置评。

Tether是稳定币领域的领跑者,这是一种将其价值与法定货币挂钩的数字资产,其USDT代币与美元挂钩,市值为1720亿美元。它是迄今为止最大的稳定币,排名第二的Circle的USDC稳定币价值约740亿美元。

Tether通过将其代币的储备金存放在包括美国国债在内的类现金资产中赚取利息,已赚取了巨额财富。根据该公司7月份的一篇博客文章,其在第二季度实现了49亿美元的利润。Tether首席执行官Paolo Ardoino最近声称,Tether的利润率高达99%。Tether引用的数字不受上市公司披露准则的约束。

过去几个月,Tether一直在为重返美国市场铺路,以期利用美国总统特朗普的亲加密政策。它最近公布了一项美国监管的稳定币计划,并任命了前白宫加密货币官员Hines来领导该计划。

在与监管机构发生冲突后,Tether在特朗普第二任期前在美国市场一直明显缺席。2021年,该公司支付了4100万美元的罚款,以了结其对其储备金存在虚假陈述的指控。

知情人士说,在过去几周,潜在投资人在过去的几周里已经获得了进入资料室的权限,以决定是否参与这次新的融资。他们预计这笔交易将在年底前完成。

İlgili Okumalar

Not Chasing AI or Buying Back Shares, Can 'Stingy' Jingdong Still Succeed?

On August 13th, JD.com (JD.US) released its Q2 2026 earnings, delivering a mixed and generally "flat" performance that met low expectations but offered few positives. Overall revenue declined by approximately 3% year-over-year (YoY) to ~¥346.4 billion, aligning with weakened domestic consumption trends. While group operating profit saw a YoY improvement, this was primarily due to reduced losses in the food delivery segment compared to the high-cost "delivery war" period of the previous year. Key details reveal deeper concerns: revenue from JD's core domestic retail segment fell 4.7% YoY. While electronics sales declined less than feared (~12% YoY), growth in daily necessities and advertising services plummeted by about 10 percentage points each, raising doubts about the segment's mid-term growth momentum post-subsidy adjustments. Logistics revenue growth also slowed to 5.9% as the delivery boom faded. Profitability presented a nuanced picture. The retail segment's operating margin edged up slightly YoY but failed to deliver the significant beats seen in past quarters, suggesting efficiency gains may be nearing limits. Losses from the New Businesses segment (including food delivery and overseas ventures) remained elevated at ~¥9.9 billion, as increased overseas investment partially offset reductions in delivery subsidies. Notably, JD's shareholder returns weakened significantly, with share buybacks in H1 2026 annualizing to only about 5% of market cap. The company opted to park cash in short-term investments rather than boost returns, drawing criticism. Looking ahead, JD's performance hinges on a potential recovery in China's e-commerce sentiment in H2 2026 and the scale of ongoing losses in new ventures. While not burdened by massive AI capex like some peers, and offering relative defensive stability, the lack of positive earnings surprises and diminished shareholder returns provide little compelling reason for investors to favor the stock in the near term.

marsbit8 dk önce

Not Chasing AI or Buying Back Shares, Can 'Stingy' Jingdong Still Succeed?

marsbit8 dk önce

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

Anthropic, an AI company nearing trillion-dollar valuation, faces a critical internal challenge: declining morale and a growing rift over its foundational beliefs and leadership. While financial and technical performance remains strong, with Q2 2026 revenue surging over 14x year-over-year and top talent like Google's Justin Gilmer joining, the company's unique culture is under strain. Early employees, who embraced a strong mission-focused culture around AI safety, now coexist with newer hires less aligned with this vision. Anonymous sources report low morale, private channels for airing grievances, and employees torn between staying for valuable equity or leaving due to pressure. CEO Dario Amodei's intense focus on maintaining culture—through rituals like "Dario Vision Quest" meetings and probing "cultural interviews"—faces scrutiny as the company scales. A leaked statement where Amodei suggested Anthropic could one day become "the world's only private company" has fueled external criticism, drawing comparisons to dystopian sci-fi monopolies. The company exhibits contradictions: advocating for AI safety while aggressively pursuing model development and market dominance. It has modified its "Responsible Scaling Policy," faced backlash for attempted AI "sabotage" mechanisms against foreign research, and clashed with the U.S. government over defense contracts. Recent text watermarking for Claude, cited as compliance with EU regulations, has also drawn user criticism. Despite these tensions, Anthropic continues to attract investment, top engineers, and enterprise clients. However, the core "faith" that once unified and distinguished it is now becoming a significant governance and cultural challenge.

marsbit44 dk önce

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

marsbit44 dk önce

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

Anthropic CEO Dario Amodei has published a rare, lengthy public statement to counter significant criticism from Silicon Valley, as the AI company approaches a potential record-breaking IPO with a reported $2 trillion valuation. The core criticism, amplified by investor Gavin Baker, centers on perceptions that Amodei believes Anthropic should be the world's sole private AI company due to the technology's risks, costs, and power—a view allegedly echoed by NVIDIA's Jensen Huang. Amodei firmly rejects this, arguing it presents a false dichotomy. He defends Anthropic's advocacy for regulation, like California's SB-1047, which he claims imposes costs on frontier AI firms while benefiting smaller competitors, and calls for establishing rules that manage AI risks, constrain corporate power, and preserve open-model development. Shifting to ambition, Amodei outlines a radical vision for AI in biomedicine. He states that within 5-10 years, AI could cure most human diseases, a mission deeply personal due to his father's death from hepatitis C just years before a cure became available. Amodei asserts that public trust in AI will be earned not by promises or benchmarks, but by tangible results—AI actually saving lives. He confirms Anthropic is significantly increasing its biology and medical AI investments, with preliminary results expected within months. This narrative reframing comes ahead of Anthropic's anticipated IPO, positioning the company not just as an OpenAI competitor, but as one aiming to solve humanity's fundamental challenges.

marsbit44 dk önce

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

marsbit44 dk önce

İşlemler

Spot
活动图片